Robert E. Parson

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Jerome P. Richie, Alan W. Partin, Peter T. Scardino, 1998, JAMA.